American Journal of Kidney Diseases
Volume 55, Issue 5 , Pages 867-874 , May 2010

Hemoglobin A1c and Fructosamine for Assessing Glycemic Control in Diabetic Patients With CKD Stages 3 and 4

  • Harn-Shen Chen, MD, PhD

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Corresponding Author InformationAddress correspondence to Harn-Shen Chen, MD, PhD, Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC, 201, Sec. 2, Shih-Pai Rd, Taipei, Taiwan
    • ,
  • Tzu-En Wu, MD

      Affiliations

    • Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Institute of Public Health and National Yang-Ming University School of Medicine, Taipei, Taiwan
    • ,
  • Hong-Da Lin, MD

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • ,
  • Tjin-Shing Jap, MD

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • ,
  • Li-Chuan Hsiao, BSC

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • Shen-Hung Lee, BSC

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • Shu-Hsia Lin, BSC

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

Received 8 July 2009 ,Accepted 27 October 2009.

References 

  1. US Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;http://www.usrds.org/adr_2008.htmAccessed June 11, 2009
  2. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289(24):3273–3277
  3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986
  4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853
  5. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH. Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004;66(4):1596–1605
  6. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int. 2001;60(1):277–283
  7. Menon V, Greene T, Pereira AA, et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol. 2005;16(11):3411–3417
  8. American Diabetes Association. Tests of glycemia in diabetes (position statement). Diabetes Care. 2000;23(suppl 1):S80–S82
  9. Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care. 2004;27(7):1761–1773
  10. The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care. 1987;10(1):1–19
  11. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25(2):275–278
  12. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJA1c-Derived Average Glucose Study Group. Translating the A1c assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473–1478
  13. Eschbach JW, Funk D, Adamson J, Kuhn I, Scribner BH, Finch CA. Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med. 1967;276(12):653–658
  14. Flückiger R, Harmon W, Meier W, Loo S, Gabbay KH. Hemoglobin carbamylation in uremia. N Engl J Med. 1981;304(14):823–827
  15. Panzer S, Kronik G, Lechner K, Bettelheim P, Neumann E, Dudczak R. Glycated hemoglobins (Ghb): an index of red cell survival. Blood. 1982;59(6):1348–1350
  16. Ansari A, Thomas S, Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis. 2003;41(3):523–531
  17. Paisey R, Banks R, Holton R, et al. Glycosylated haemoglobin in uraemia. Diabet Med. 1986;3(5):445–448
  18. Service JF. Correlation between glycemia and glycated hemoglobin. Compr Ther. 1990;16(1):33–40
  19. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM. Tests of glycemia in diabetes. Diabetes Care. 1995;18(6):896–909
  20. Joy MS, Cefalu WT, Hogan SL, Nachman PH. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis. 2002;39(2):297–307
  21. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473–2483
  22. Howey JE, Browning MC, Fraser CG. Assay of serum fructosamine that minimizes standardization and matrix problems: use to assess components of biological variation. Clin Chem. 1987;33(2 pt 1):269–272
  23. Larsen ML, Hørder M, Mogensen EF. Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med. 1990;323(15):1021–1025
  24. Lamb E, Mainwaring-Burton R, Dawnay A. Effect of protein concentration on the formation of glycated albumin and fructosamine. Clin Chem. 1991;37(12):2138–2139
  25. Schleicher ED, Olgemöller B, Wiedenmann E, Gerbitz KD. Specific glycation of albumin depends on its half-life. Clin Chem. 1993;39(4):625–628

 Originally published online as doi:10.1053/j.ajkd.2009.10.064 on March 4, 2010.

PII: S0272-6386(09)01665-5

doi: 10.1053/j.ajkd.2009.10.064

American Journal of Kidney Diseases
Volume 55, Issue 5 , Pages 867-874 , May 2010

Article Tools

* Image Usage & Resolution